Fibrinogen alpha Chain (FGA) Peptide
FGA
Reactivity: Human
Host: Synthetic
BP, WB, IHC
-
- Target See all FGA products
- FGA (Fibrinogen alpha Chain (FGA))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-FGA antibody (Catalog #: ARP41758_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- FGA (Fibrinogen alpha Chain (FGA))
- Synonyms
- Fib2 Peptide, ENSMUSG00000059807 Peptide, Fib Peptide, Ac1873 Peptide, Fba5e Peptide, fibrinogen alpha chain Peptide, FGA Peptide, Fga Peptide, LOC698244 Peptide
- Background
-
FGA is the alpha component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in its gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia, afibrinogenemia and renal amyloidosis.The protein encoded by this gene is the alpha component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia, afibrinogenemia and renal amyloidosis. Alternative splicing results in two isoforms which vary in the carboxy-terminus.
Alias Symbols: Fib2
Protein Interaction Partner: BAT2,CDH5,F13A1,F2,FGA,FGB,FGG,HRG,ITGA2B,ITGB3,NID1,PLAT,SERPINA5,SERPINF2,THBS1,BAT2,CDH5,F13A1,F2,FGA,FGB,FGG,HRG,KHDRBS2,NID1,PLAT,THBS1
Protein Size: 644 - Molecular Weight
- 71 kDa
- Gene ID
- 2243
- NCBI Accession
- NM_021871, NP_068657
- UniProt
- Q4QQH7
-
You are here:
